News on Hair_Follicle from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hair_Follicle news from BioPortfolio.com Wed, 10 Feb 2010 10:58:55 GMT en Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988607&HITNO=0&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988607&THISHREF=http://c.moreover.com/click/here.pl%3fz2511263807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988607&HITNO=0&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988607&THISHREF=http://c.moreover.com/click/here.pl%3fz2511263807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Merck Receives European Approval for ELONVA (corifollitropin alfa injection), a New Fertility ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988370&HITNO=1&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988370&THISHREF=http://c.moreover.com/click/here.pl%3fz2510955416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988370&HITNO=1&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988370&THISHREF=http://c.moreover.com/click/here.pl%3fz2510955416%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Merck Receives European Approval for ELONVA (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981436&HITNO=2&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981436&THISHREF=http://c.moreover.com/click/here.pl%3fz2506986444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3981436&HITNO=2&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3981436&THISHREF=http://c.moreover.com/click/here.pl%3fz2506986444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Merck Receives European Approval for Elonva (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979696&HITNO=3&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979696&THISHREF=http://c.moreover.com/click/here.pl%3fz2505921334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979696&HITNO=3&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979696&THISHREF=http://c.moreover.com/click/here.pl%3fz2505921334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3977749&HITNO=4&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3977749&THISHREF=http://c.moreover.com/click/here.pl%3fz2504960324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3977749&HITNO=4&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3977749&THISHREF=http://c.moreover.com/click/here.pl%3fz2504960324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTickerTech.com: Merck Receives European Approval for Elonva (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976581&HITNO=5&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976581&THISHREF=http://c.moreover.com/click/here.pl%3fz2504423400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3976581&HITNO=5&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3976581&THISHREF=http://c.moreover.com/click/here.pl%3fz2504423400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Merck's Follicle Stimulent Elonva Granted European Commission Approval - Updatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975702&HITNO=6&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975702&THISHREF=http://c.moreover.com/click/here.pl%3fz2504134365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975702&HITNO=6&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975702&THISHREF=http://c.moreover.com/click/here.pl%3fz2504134365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRTTNews.com: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975237&HITNO=7&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975237&THISHREF=http://c.moreover.com/click/here.pl%3fz2503962989%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975237&HITNO=7&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975237&THISHREF=http://c.moreover.com/click/here.pl%3fz2503962989%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPittsburgh Business Times: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975234&HITNO=8&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975234&THISHREF=http://c.moreover.com/click/here.pl%3fz2503962159%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975234&HITNO=8&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975234&THISHREF=http://c.moreover.com/click/here.pl%3fz2503962159%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNew Mexico Business Weekly: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975228&HITNO=9&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975228&THISHREF=http://c.moreover.com/click/here.pl%3fz2503959325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975228&HITNO=9&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975228&THISHREF=http://c.moreover.com/click/here.pl%3fz2503959325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTriad Business Journal: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975076&HITNO=10&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975076&THISHREF=http://c.moreover.com/click/here.pl%3fz2503883256%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975076&HITNO=10&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975076&THISHREF=http://c.moreover.com/click/here.pl%3fz2503883256%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975074&HITNO=11&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975074&THISHREF=http://c.moreover.com/click/here.pl%3fz2503882885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975074&HITNO=11&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975074&THISHREF=http://c.moreover.com/click/here.pl%3fz2503882885%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Journal of Milwaukee: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975063&HITNO=12&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975063&THISHREF=http://c.moreover.com/click/here.pl%3fz2503875306%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975063&HITNO=12&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975063&THISHREF=http://c.moreover.com/click/here.pl%3fz2503875306%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOrlando Business Journal: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975061&HITNO=13&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975061&THISHREF=http://c.moreover.com/click/here.pl%3fz2503874011%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3975061&HITNO=13&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3975061&THISHREF=http://c.moreover.com/click/here.pl%3fz2503874011%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWichita Business Journal: Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974973&HITNO=14&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974973&THISHREF=http://c.moreover.com/click/here.pl%3fz2503821538%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974973&HITNO=14&MSIZE=51&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hair_Follicle&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974973&THISHREF=http://c.moreover.com/click/here.pl%3fz2503821538%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: